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Relative risk estimates for fatal overdose vary within and between classes of antidepressants. Tricyclic antidepressants (TCAs) have consistently been associated with the highest toxicity in overdose. SSRIs, on the other hand, are the least toxic in overdose, with approximately one-tenth the death rates associated with TCAs.
1 Venlafaxine appears to fall somewhere in between (Table 1) . Putting the numbers into perspective, the annual suicide rate in Canada is about 13.5 per 100 000 in the general population; higher, among patients receiving psychiatric treatment. Deliberate antidepressant overdoses account for 4%-7% of all suicides;
1 one-third of fatal antidepressant overdoses also include alcohol or other drugs.
2
The reasons for the increased overdose fatalities associated with venlafaxine are not entirely clear. Competing explanations include a true toxicity effect versus a "spurious" effect related to its use in higher-risk groups than those prescribed SSRIs. Some combination of these is also possible. The former explanation is supported by case reports linking cardiac illness and venlafaxine overdose.
3 The latter is supported by a study of data from the United Kingdom's General Practice Research Database, in which patients prescribed venlafaxine were more likely than patients prescribed SSRIs to have been admitted to hospital for depression, to have displayed suicidal behaviour and to have received co-prescriptions of antipsychotic medications.
5 Unfortunately, the data did not include specifics on the doses consumed, duration of drug use or comorbid illnesses.
W Wh ha at t t to o d do o: : The US manufacturer has issued a warning stating that "prescriptions for Effexor should be written for the smallest quantity of capsules consistent with good patient management, in order to reduce the risk of overdose." This is difficult to apply across a wide spectrum of prescribing patterns. If venlafaxine is used as a second-or third-line drug for the treatment of depression, its use may signal the need for a more indepth assessment of suicide risk and perhaps more intensive treatment.
Regardless of the role of patient risk factors, it is important to be aware of plausible arguments that venlafaxine is more toxic in overdose than SSRIs but less so than TCAs. A definitive explanation of the observed effect will have to wait upon more specific information.
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